Search JIM Advanced Search

Journal of Integrative Medicine ›› 2020, Vol. 18 ›› Issue (3): 229-241.doi: 10.1016/j.joim.2020.03.004

• Original Experimental Research • Previous Articles     Next Articles

Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: network-molecular docking-LC-MSE analysis

Zi-jia Zhanga, Wen-yong Wua,b, Jin-jun Houa, Lin-lin Zhanga, Fei-fei Lia,b, Lei Gaoa,b, Xing-dong Wua, Jing-ying Shia,b, Rong Zhanga,b, Hua-li Longa, Min Leia, Wan-ying Wua, De-an Guoa, Kai-xian Chena, Lewis A. Hofmannc, Zhonghua Cic   

  1. a Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
    b University of Chinese Academy of Sciences, Beijing 100049, China
    c World Health Science Organization, Virginia Leesburg 20176, USA
  • Received:2020-03-13 Accepted:2020-03-17 Online:2020-05-08 Published:2020-03-20
  • About author:Zi-jia Zhang, Wen-yong Wu and Jin-jun Hou made equal contribution to this work.
  • Supported by:

    We are grateful for the financial support from National Key Research and Development Program of China (No. 2018YFC1707900)


The Lung-toxin Dispelling Formula No.1 (referred to as Respiratory Detox Shot, RDS) was established based on the theory of traditional Chinese medicine (TCM) medicinal properties and the classical prescription of TCM. It has demonstrated therapeutic benefits in both disease control and prevention in the effort to contain corona virus disease 2019 (COVID-19). However, the material basis and action mechanism of RDS are still unclear. The goal of the study is to clarify the material foundation and action mechanism of RDS.


To achieve in-depth analyses of RDS from a holistic perspective, an integrative analytical platform was constructed, including target prediction, protein-protein interaction (PPI) network, cluster analysis, and the hub genes involved in the disease pathways were identified, and their corresponding compounds were further applied to molecular docking for in vitro biological validation. The presence of the validated compounds was also measured to demonstrate the material basis of RDS. In our network pharmacology study, a total of 26 bioinformatic software and databases were accessed, and 6 networks covering the entire Zang-fu viscera were constructed to achieve comprehensive analysis and visualization of the intricate connections among the compounds-targets-disease pathway-meridians of RDS.


For all 1071 compounds of 9 ingredients of RDS from established TCM databases, 157 compounds passed drug-likeness screening and led to 339 predicted targets in the compound-target network. 42 hub genes with core regulatory effects were extracted from the PPI network, and 134 compounds and 29 crucial disease pathways were implicated in the target-compound-disease network. Twelve disease pathways attributed to Lung-Large intestine meridian, with 6 and 5 to Kidney-Urinary bladder and Stomach-Spleen meridians, respectively. 118 candidate compounds showed a high binding affinity with SARS-CoV-2 3-chymotrypsin-like protease (3CLpro) by molecular docking using computational pattern recognition. The in vitro activity of 22 compounds was validated by the 3CLpro inhibition assay. Finally, using the technique of liquid chromatography mass spectrometry in data-independent analysis mode, 7 out of 22 compounds were confirmed and validated in RDS aqueous decoction with reference standards in both non-targeted and targeted approaches.


Our results unveiled that RDS acts primarily in the Lung-Large intestine, Kidney-Urinary bladder, and Stomach-Spleen meridians, with other Zang-fu viscera strategically covered by all 9 ingredients. Integrated with the context of TCM meridian theory, multiple components and targets of RDS demonstrate the action dual effects of health-strengthening and pathogen-eliminating in one prescription to achieve systemic therapeutic effects for early COVID-19 control and prevention.

Key words: Lung-toxin Dispelling Formula No.1, COVID-19, Severe acute respiratory syndrome coronavirus 2, 3C-like protease, SARS coronavirus, Network pharmacology, Molecular docking molecular docking, LC-MSE, Meridian tropism, Zang-fu (viscera)

[1] Arthur Yin Fan, Sherman Gu, Sarah Faggert Alemi, Research Group for Evidence-based Chinese Medicine. Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis. Journal of Integrative Medicine, 2020, 18(5): 385-394.
[2] Jian-zhong Dang, Gang-yan Zhu, Ying-jie Yang, Fang Zheng. Clinical characteristics of coronavirus disease 2019 in patients aged 80 years and older. Journal of Integrative Medicine, 2020, 18(5): 395-400.
[3] Deng-hai Zhang, Kun-lun Wu, Xue Zhang, Sheng-qiong Deng, Bin Peng. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. Journal of Integrative Medicine, 2020, 18(2): 152-158.
[4] Chang-quan Ling. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of Integrative Medicine, 2020, 18(2): 87-88.
Full text



[1] Wei Gu, Jie Shen, Xiao-feng Zhai. Preliminary study on biological behavior and staging of transplanted hepatoma in rats. Journal of Chinese Integrative Medicine, 2005, 3(2): 136-138
[2] Ying-lu Feng, Chang-quan Ling, De-zeng Zhu, Chao-qin Yu, Zhe Chen, Bai Li. Ginsenosides combined with dexamethasone in preventing and treating postembolization syndrome following transcatheter arterial chemoembolization: A randomized, controlled and double-blinded prospective trial. Journal of Chinese Integrative Medicine, 2005, 3(2): 99-102
[3] Chuan-yue Niu. On truthfulness in light of the English translation of the nomenclature of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2005, 3(3): 247-250
[4] Yan-hao Xiong, Ning Du, Wei-zhen Chen, Tao Liu, Xu-sheng Tang. Retrospective study of the relationship of height difference and bone density of postmenopausal women. Journal of Chinese Integrative Medicine, 2003, 1(4): 265-267
[5] Yong Tang, Hai-yan Yin, Fang Zeng, Shu-guang Yu. Pondering in-situ induction of endogenous neural stem cells in hippocampus of rats with Alzheimer disease by acupuncture. Journal of Chinese Integrative Medicine, 2005, 3(5): 351-354
[6] Xiao-dong Guan, Yu-fang Wu, Wen Zhao. Clinical observation on treatment of IgA nephropathy with Huobahuagen Tablets and irbesartan. Journal of Chinese Integrative Medicine, 2005, 3(5): 366-369
[7] Li-qing Li, Li-li Huo, Xin-guang Zhang, Jian-er Yu. Progress in research on relationship between bronchial asthma and Th1/Th2 imbalance. Journal of Chinese Integrative Medicine, 2005, 3(5): 403-407
[8] Shi-li Jiang, Xu-dong Hu, Ping Liu. Immunomodulation and liver protection of Yinchenhao decoction against concanavalin A-induced chronic liver injury in mice. Journal of Integrative Medicine, 2015, 13(4): 262-268
[9] Kumar Dinesh, Kumar Sunil, Taprial Seema, Kashyap Deepak, Kumar Ajay, Prakash Om. A review of chemical and biological profile of genus Michelia. Journal of Chinese Integrative Medicine, 2012, 10(12): 1336-1340
[10] De-bo Qi, Wei-min Li. Effects of electroacupuncture on expression of c-fos protein in the spinal dorsal horn of rats with chronic visceral hyperalgesia. Journal of Chinese Integrative Medicine, 2012, 10(12): 1490-1496